Skip to content
Bomb Report – Lifestyle
Author:
Sanofi Winthrop Industrie
Press release: Availability of the Q1 2026 aide-mémoire
March 24, 2026
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis
March 5, 2026
←
Previous Page
1
2
3
4